Aktis Oncology Inc.
AKTS | NASDAQ
$15.93
-$0.92 (-5.46%)
At close: Oct 30, 2026, 4:00 PM ET
$15.93
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Institutional Ownership
Net OutflowTotal Institutions
116
Total Ownership
62.12%
Capital Flow
-$485.77M
Shares Change
-371.7K
Ownership Distribution
Institutions (62.12%)
Others (37.88%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
55
Increased Positions
83
Reduced Positions
17
Closed Positions
8
New (55)
Increased (83)
Reduced (17)
Closed (8)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Soros Fund Management LLC | 0.18% 0.00% | 0.03% | 100K | 1.69M | |
| Renaissance Technologies LLC | 0.17% 0.00% | < 0.01% | 95.4K | 1.61M | |
| Polen Capital Management LLC | 0.11% 0.00% | < 0.01% | 63.51K | 1.07M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Mpm Bioimpact LLC | 8.74% -0.08% | 9.50% +42.25% | 4.84M 0.00% | 155.86M +80.16% | |
| Ecor1 Capital, LLC | 8.72% -0.08% | 7.56% +106.40% | 4.82M 0.00% | 155.49M +80.16% | |
| Blue Owl Capital Holdings LP | 5.55% -2.96% | 14.89% -2.01% | 3.07M -2.88% | 98.95M +74.96% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove AKTS